FDA Import Refusal KM6-0110488-8/14/1 — Glaxo Smithkline Pakistan Limited
The FDA refused shipment KM6-0110488-8/14/1 from Glaxo Smithkline Pakistan Limited (Pakistan) on May 14, 2009. The refused product falls under Drugs and Biologics — ANTACID, N.E.C.. Cited charges: 118,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- May 14, 2009
- Country
- Pakistan
- Product Category
- Drugs and Biologics
- Product Code
- 60SBR99 ANTACID, N.E.C.
- Charges
- 118,75